fluorouracil and xav939
fluorouracil has been researched along with xav939 in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, J; Liu, K; Luo, F; Wu, X; Zhong, X | 1 |
Hua, D; Lu, TX; Ning, K; Wang, T | 1 |
Abduljabbar, A; Ahmed, SO; Al-Dayel, F; Al-Kuraya, KS; Al-Sanea, N; Ashari, LH; Begum, R; Concepcion, RMJA; Kumar Parvathareddy, S; Melosantos, R; Padmaja Divya, S; Pratheeshkumar, P; Siraj, AK | 1 |
Other Studies
3 other study(ies) available for fluorouracil and xav939
Article | Year |
---|---|
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.
Topics: Apoptosis; Axin Protein; beta Catenin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colonic Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Neoplastic Stem Cells; Tankyrases; Wnt Signaling Pathway | 2016 |
Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
Topics: Aged; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Heterocyclic Compounds, 3-Ring; Humans; Male; Middle Aged; Treatment Failure; TRPC Cation Channels; Wnt Signaling Pathway | 2017 |
APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy.
Topics: Adenomatous Polyposis Coli; Aged; Antimetabolites, Antineoplastic; Cell Line, Tumor; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; Heterocyclic Compounds, 3-Ring; Humans; Male; Middle Aged; Mutation; Saudi Arabia; Survival; Tankyrases; Wnt Signaling Pathway | 2020 |